Therapeuticsmd Inc (TXMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -172,415 | -129,455 | -82,035 | -39,383 | -183,524 |
| Depreciation Amortization | 736 | 3,091 | 2,061 | 1,019 | 4,067 |
| Accounts receivable | N/A | -5,560 | -1,544 | -1,567 | -8,224 |
| Accounts payable and accrued liabilities | -1,062 | -1,476 | -6,503 | -10,758 | 1,887 |
| Other Working Capital | 4,591 | 5,026 | 6,035 | -4,691 | 3,864 |
| Other Operating Activity | 113,017 | 25,239 | 17,074 | 17,000 | 22,459 |
| Operating Cash Flow | $-55,133 | $-103,135 | $-64,912 | $-38,380 | $-159,471 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -34 | -34 | -104 | -63 | -207 |
| Purchase Sale Intangibles | -2,189 | -675 | -423 | -375 | -1,391 |
| Other Investing Activity | -2,189 | -675 | -423 | -375 | -1,391 |
| Investing Cash Flow | $-2,223 | $-709 | $-527 | $-438 | $-1,598 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 50,000 |
| Common Stock Issued | 184,670 | 183,317 | 151,495 | 150,949 | 31,975 |
| Other Financing Activity | -55,118 | -55,118 | -55,118 | -55,000 | -1,250 |
| Financing Cash Flow | $129,552 | $128,199 | $96,377 | $95,949 | $80,725 |
| Beginning Cash Position | 80,486 | 80,486 | 80,486 | 80,486 | 160,830 |
| End Cash Position | 65,122 | 104,841 | 111,424 | 137,617 | 80,486 |
| Net Cash Flow | $-15,364 | $24,355 | $30,938 | $57,131 | $-80,344 |
| Free Cash Flow | |||||
| Operating Cash Flow | -55,133 | -103,135 | -64,912 | -38,380 | -159,471 |
| Capital Expenditure | -34 | -34 | -104 | -63 | -207 |
| Free Cash Flow | -55,167 | -103,169 | -65,016 | -38,443 | -159,678 |